<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682211/" ref="ordinalpos=2071&amp;ncbi_uid=4989467&amp;link_uid=PMC3682211" image-link="/pmc/articles/PMC3682211/figure/F7/" class="imagepopup">Figure 7.  From: Aspirin Inhibits mTOR <span class="highlight" style="background-color:">Signaling</span>, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells. </a></div><br /><div class="p4l_captionBody">Aspirin targets multiple components of the AMPK/mTOR signaling pathway in colorectal cancer. Aspirin increases phosphorylation of AMPK and ULK1. Aspirin inhibits mTOR signaling as evidenced by decreased phosphorylation of S6K1, S6, and 4E-BP1. Hence, aspirin is targeting multiple cellular pathways involved in mRNA stability, cell cycle, autophagy, protein translation, and ribosome biogenesis.</div></div>